New and Unproved Medical Devices

Kesselheim AS, Avorn J - BMJ

  • Regulation and Clinical Evidence

Summary:

The rapid adoption of new medical devices by “innovator” and “early adopter” surgeons—as demonstrated by half of hip prosthesis brands in use having been on the market less than three years—poses public health risks because most devices are cleared through the 510(k) pathway without clinical effectiveness testing.

VIEW SOURCE

Recent Work from PORTAL

Talk bubble graphics representing commentary and opinion.

How Congress Can Fix Expert Advisory Committees

Daval CJR, Kesselheim AS - STAT

  • Regulation and Clinical Evidence
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

International Regulatory Status and Reimbursement Recommendations of Haematological Malignancy Drugs Withdrawn from the FDA Accelerated Approval Pathway

Mulsant SS, Kesselheim AS, Naci H - Journal of Cancer Policy

  • Price, Value, and Access
  • Regulation and Clinical Evidence
Talk bubble graphics representing commentary and opinion.

The Impact of Semantics in Medicines Regulation

Costa E, Kesselheim AS - Journal of Law, Medicine, & Ethics

  • Innovation Incentives and Competition
  • Regulation and Clinical Evidence